Latest Real-time polymerase chain reaction Stories
SAN DIEGO, May 9, 2013 /PRNewswire/ -- TriLink BioTechnologies, Inc. (TriLink, www.trilinkbiotech.com), a leader in manufacturing high quality oligonucleotides, nucleoside triphosphates and mRNA, announced that it has signed a licensing agreement with QuantiBact A/S (QuantiBact, www.quantibact.com) to offer twisted intercalating nucleic acid (TINA) modified oligos. TINA molecules are intercalators placed at the 5' end of primers to stabilize duplex formation. Their unique properties...
Superior Accuracy and On-Demand Validated Assays Covering the Whole Exome Enable Major Clinical Sequencing Providers FREMONT, Calif., May 9, 2013 /PRNewswire/ -- WaferGen Bio-systems, Inc. (OTCBB: WGBS) today announced the launch of its new SmartChip TE product - a PCR-based target enrichment solution for sample preparation prior to targeted re-sequencing on Next-Gen platforms. As clinical Next-Gen sequencing rapidly expands into the mainstream molecular testing market, the growth...
IPSWICH, Mass. and NORTHAMPTON, Mass., May 1, 2013 /PRNewswire/ -- This summer, Smith College is hosting the 28(th) annual Molecular Biology Summer Workshops at the Ford Science Center in Northampton, MA. In cooperation with New England Biolabs (NEB), a leader in the research and development of reagents for the life sciences, Smith College invites interested parties to learn molecular biology in this intensive workshop, set against the peaceful and picturesque backdrop of the Smith...
MOUNTAIN VIEW, Calif., May 1, 2013 /PRNewswire/ -- Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the release of the SMARTer Universal Low Input RNA Kit for Sequencing. The SMARTer Universal Low Input RNA Kit extends Clontech's NGS (Next Generation Sequencing) solutions to include low input samples of compromised RNA. It combines Clontech's patented SMART(TM) (Switching Mechanism at 5' End of RNA Template) technology for ds cDNA synthesis...
ReportsnReports.com offers 2013 market research reports on trends in qPCR Assay, phenotypic drug discovery, benchtop automation and mass spectrometry (MS)-based screening assays. DALLAS, May 1, 2013 /PRNewswire-iReach/ -- qPCR Assay Trends 2013, Phenotypic Drug Discovery Trends 2013, Benchtop Automation Trends 2013 and Mass Spec-Based Screening Assay Trends 2013 are new reports available with ReportsnReports.com (Photo: http://photos.prnewswire.com/prnh/20130501/CG04491)...
Company's instruments FDA-cleared under Emergency Use Authorization declaration CARLSBAD, Calif., April 26, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced that its Applied Biosystems® 7500 Fast Dx Real-Time PCR instrument is the sole platform cleared for use under the Centers for Disease Control and Prevention (CDC) protocol created for emergency screenings of patients suspected of harbouring the Avian influenza (H7N9) virus, which to date has led...
GAITHERSBURG, Md., April 25, 2013 /PRNewswire/ -- Quanta BioSciences today announced the CDC Real-Time RT-PCR (rRT-PCR) Protocol LP-152 for Detection and Characterization of Avian A/H7 (Eurasian-lineage) Influenza recommends that public health and other qualified laboratories utilize Quanta's qScript One-Step qRT-PCR Kit, Low ROX (95059-200 and 95059-050). According to the World Health Organization (WHO) 108 cases of H7N9 influenza have been reported in China, causing severe...
Innovative multiplexing instrument for clinical laboratories with simultaneous testing for greater than 90% of bacterial, viral, and parasitic causes of infectious gastroenteritis in a single molecular test now available AUSTIN, Texas, April 15, 2013 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced it has received U.S. FDA clearance of its MAGPIX instrument, with its xTAG Gastrointestinal Pathogen Panel (xTAG GPP). This is the first clinical assay to be...
FDA issues 510(k) Clearance for Quidel Molecular Direct Clostridium difficile Assay and Life Technologies Real-Time PCR Instruments for Monitoring Hospital-Acquired Infections SAN DIEGO and CARLSBAD, Calif., March 18, 2013 /PRNewswire/ -- Quidel Corporation (NASDAQ: QDEL) and Life Technologies Corporation (NASDAQ: LIFE) announced today that they received 510(k) clearances from the United States Food and Drug Administration (FDA) to market the Quidel Molecular Direct C. difficile...
Key Initial Application is to Develop Chromatin-Immunoprecipitation (ChIP) PCR Methods FREMONT, Calif., March 11, 2013 /PRNewswire/ -- The Salk Institute and WaferGen Bio-systems, Inc. (OTCBB: WGBS) today announced the formation of a nano-qPCR Core Laboratory under the guidance of Ronald M. Evans, Professor and March of Dimes Chair in Molecular and Developmental Biology at Salk. The lab will utilize WaferGen's SmartChip System as the backbone technology for high-throughput...
